Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012

Details for Mechanism ID: 9472
Country/Region: South Africa
Year: 2012
Main Partner: Boston University
Main Partner Program: NA
Organizational Type: University
Funding Agency: USAID
Total Funding: $431,752

Boston University, with its local partner Health Economics and Epidemiology Research Office (HE2RO) of the University of the Witwatersrand, generate accurate, current, program-relevant information about the outcomes, costs, cost-effectiveness, and benefits of HIV/AIDS and TB prevention, care, and treatment interventions. The project includes evaluations in five main areas: 1. Estimating the costs and cost-effectiveness of adult and pediatric HIV treatment delivery2. National modeling of the costs of HIV care and treatment and PMTCT3. Reducing loss to pre-ART care and promoting earlier treatment initiation4. Improving treatment outcomes through epidemiological analysis of PEPFAR partner data5. Economic evaluation and modeling of TB and HIV/TB integration (case finding, diagnosis, treatment)Each of these areas is a priority under Pillars 1 and 2 of the NSP and the Partnership Framework principles of sustainability, innovation, and responsiveness, as they focus on generating the knowledge base needed to identify efficient ways to deliver services, achieve health targets at the lowest cost, and ensure value for money. The project directly supports the SAG in improving budgeting and resource allocation. The project also strengthens decentralization and integration of health services by evaluating the outcomes and costs of different models of service delivery (e.g. nurse-managed HIV treatment and use of point-of-care TB diagnostics and CD4 tests).

Funding for Treatment: Adult Treatment (HTXS): $431,752

The budget will be divided among the five technical areas of work described in the Overview Narrative as follows:

1. Cost and cost-effectiveness of HIV treatment delivery: $107,9382. Modeling of treatment costs: $43,1753. Loss to pre-ART care/earlier treatment initiation: $107,9384. Improving treatment outcomes: $43,1755. Economics of TB: $129,527

All of these activities involve tracking and evaluating clinical outcomes, improving program performance, and increasing efficiency of service delivery. Area 3 specifically addresses efforts to improve the transition to care and retention of patients in pre-ART care, while Area 4 generates information about retention and adherence after ART initiation. Area 5 pertains to the development of a comprehensive package of care that includes TB screening, diagnosis, and treatment. Areas 1 and 2 are aimed at generating site-level and national data to improve access to services and the sustainability of service delivery and to strengthen local ownership.

Subpartners Total: $0
University of the Witwatersrand: NA
Cross Cutting Budget Categories and Known Amounts Total: $64,762
Human Resources for Health $64,762
Key Issues Identified in Mechanism